Sarepta Therapeutics (SRPT) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187.09% |
| Dec 31, 2025 | -298.09% |
| Sep 30, 2025 | -189.45% |
| Jun 30, 2025 | 138.48% |
| Mar 31, 2025 | -285.79% |
| Dec 31, 2024 | 628.42% |
| Sep 30, 2024 | 3,266.33% |
| Jun 30, 2024 | -102.01% |
| Mar 31, 2024 | 41.75% |
| Dec 31, 2023 | 218.15% |
| Sep 30, 2023 | 84.39% |
| Jun 30, 2023 | 3.31% |
| Mar 31, 2023 | -29.26% |
| Dec 31, 2022 | 18.67% |
| Sep 30, 2022 | 37.79% |
| Jun 30, 2022 | -143.01% |
| Mar 31, 2022 | 17.89% |
| Dec 31, 2021 | -207.08% |
| Sep 30, 2021 | 79.44% |
| Jun 30, 2021 | -10.34% |
| Mar 31, 2021 | 11.04% |
| Dec 31, 2020 | -24.55% |
| Sep 30, 2020 | 0.93% |
| Jun 30, 2020 | -17.22% |
| Mar 31, 2020 | 48.73% |
| Dec 31, 2019 | -86.28% |
| Sep 30, 2019 | 55.12% |
| Jun 30, 2019 | -260.49% |
| Mar 31, 2019 | 45.19% |
| Dec 31, 2018 | -98.81% |
| Sep 30, 2018 | 32.22% |
| Jun 30, 2018 | -236.47% |
| Mar 31, 2018 | -32.80% |
| Dec 31, 2017 | 49.58% |
| Sep 30, 2017 | 27.52% |
| Jun 30, 2017 | -61.39% |
| Mar 31, 2017 | 55.60% |
| Dec 31, 2016 | -56.36% |
| Sep 30, 2016 | 8.96% |
| Jun 30, 2016 | -4.02% |
| Mar 31, 2016 | 7.37% |
| Dec 31, 2015 | -24.51% |
| Sep 30, 2015 | -22.93% |
| Jun 30, 2015 | 31.93% |
| Mar 31, 2015 | -38.33% |
| Dec 31, 2014 | -32.80% |
| Sep 30, 2014 | -11.25% |
| Jun 30, 2014 | -20.50% |
| Mar 31, 2014 | 23.53% |
| Dec 31, 2013 | -31.75% |
| Sep 30, 2013 | -45.92% |
| Jun 30, 2013 | -10.85% |
| Mar 31, 2013 | -48.71% |
| Dec 31, 2012 | -50.12% |
| Sep 30, 2012 | -24.26% |
| Jun 30, 2012 | 19.16% |
| Mar 31, 2012 | 23.62% |
| Dec 31, 2011 | 20.15% |
| Sep 30, 2011 | -11.32% |
| Jun 30, 2011 | -83.06% |
| Mar 31, 2011 | -217.87% |
| Dec 31, 2010 | 54.17% |
| Sep 30, 2010 | 50.48% |